Multi vessel coronary artery disease
Information
- Disease name
- Multi vessel coronary artery disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05464147 | Active, not recruiting | N/A | DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions | October 19, 2021 | October 2024 |
NCT03298659 | Active, not recruiting | N/A | iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction | December 21, 2017 | February 23, 2027 |
NCT03424941 | Active, not recruiting | N/A | The TransCatheter Valve and Vessels Trial | May 31, 2018 | November 1, 2024 |
NCT06039059 | Completed | Influence of Risk Factors on ISR and Nonintervened Lesions | January 1, 2020 | March 31, 2023 | |
NCT03252990 | Completed | 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability | March 2, 2018 | December 6, 2019 | |
NCT02546557 | Completed | Optilene® Suture for Coronary Artery Bypass Graft Surgery | November 10, 2015 | October 2018 | |
NCT03138473 | Completed | Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease | July 1, 2018 | June 30, 2021 | |
NCT03455244 | Completed | Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease | November 14, 2017 | May 2, 2018 | |
NCT02325973 | Completed | N/A | Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI | June 2013 | February 2018 |
NCT04545112 | Enrolling by invitation | N/A | Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) | October 22, 2020 | March 15, 2026 |
NCT06168968 | Recruiting | Multidisciplinary Approach to Reduce Cardiovascular Health Disparities | February 6, 2023 | August 2025 | |
NCT03479593 | Recruiting | Culprit Lesions in NSTEMI With Multi Vessel Disease (NSTEMI-CULPRIT) | January 10, 2018 | January 1, 2024 | |
NCT04918030 | Recruiting | N/A | STaged Interventional Strategies for Acute ST-seGment Elevation Myocardial Infarction Patient With Multi-vessel Disease(STAGED) | February 11, 2021 | May 1, 2023 |
NCT04968808 | Recruiting | N/A | Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) | September 1, 2021 | August 31, 2025 |
NCT05230446 | Recruiting | N/A | PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions | November 18, 2021 | November 18, 2027 |
NCT05527717 | Recruiting | Phase 4 | Revascularization Strategy of Multivessel Disease for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator | November 16, 2022 | December 31, 2028 |
NCT06104033 | Recruiting | Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease | September 18, 2023 | October 31, 2026 | |
NCT04252703 | Terminated | N/A | 'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians | May 13, 2020 | January 1, 2022 |
NCT02943954 | Unknown status | N/A | FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction | December 2016 | January 2022 |
NCT05166538 | Unknown status | Phase 4 | Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass | February 1, 2022 | December 2023 |
NCT03700645 | Unknown status | Phase 4 | Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease | December 1, 2018 | January 31, 2020 |
- MedGen concept unique identifier (MedGen Concept name)
- C1299432
- MedGen unique identifier (MedGen Concept name)
- 721291